Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Pieter Sonneveld(Erasmus MC Cancer Institute), Philippe Moreau(Centre National de la Recherche Scientifique), P. Joy Ho(The University of Sydney), Wilfried Roeloffzen(University Medical Center Groningen), Véronique Vanquickelberghe(Janssen (Belgium)), Laura Rosiñol(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Hermann Einsele(Universitätsklinikum Würzburg), Mario Boccadoro(University of Turin), Francesca Gay(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Joan Bladé(Hospital Clínic de Barcelona), Niels W.C.J. van de Donk(Oncode Institute), Meletios Α. Dimopoulos(Korea University), Eirini Katodritou(Evangelismos Hospital), Silvia Mangiacavalli(Policlinico San Matteo Fondazione), Artur Jurczyszyn(Jagiellonian University), Sarah Lonergan(Erasmus MC Cancer Institute), Xavier Leleu(Inserm), Diego Vieyra(Janssen (United States)), Robin Carson(Janssen (United States)), Emilie M.J. van Brummelen(The Netherlands Cancer Institute), Annemiek Broijl(Erasmus MC Cancer Institute), Annette Juul Vangsted(Copenhagen University Hospital), Inger S. Nijhof(St. Antonius Ziekenhuis), Michèle Cavo(Unknown), Elisabetta Antonioli(Azienda Ospedaliero-Universitaria Careggi), Angelo Belotti(Fondazione Gimema Onlus), Tobias Silzle(Kantonsspital St. Gallen), Tahamtan Ahmadi(Genmab (United States)), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Anna Sitthi-Amorn(Johnson & Johnson (United States)), Fredrik Schjesvold(Oslo University Hospital), Meral Beksaç(Liv Hospital), Paula Rodríguez‐Otero(Clinica Universidad de Navarra), Aurore Perrot(Institut universitaire du cancer de Toulouse Oncopole), Cyrille Hulin(Hôpital Cardiologique du Haut-Lévêque), Roman Hájek(University Hospital Ostrava), Hang Quach(The University of Melbourne), Jianping Wang(Shandong University), Yanfang Liu(Jiangsu University), Michel Delforge(KU Leuven), Andrew Spencer(The Alfred Hospital), Carla J. de Boer(Erasmus MC Cancer Institute), Roberto Mina(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)
Cited by 538
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Hematological findings and complications of <scp>COVID</scp>‐19
|American Journal of Hematology|2020|1.7k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k